Results 171 to 180 of about 5,052,436 (221)

Efficacy and safety of intracoronary injection of recombinant human prourokinase in patients with slow blood flow/no-reflow during PCI for acute coronary syndrome: a randomised controlled, double-blind, placebo controlled, national multicentre clinical study protocol (PUK-ACS study). [PDF]

BMJ Open
Lv W, Ye Y, Xie X, Zhang Y, Wang J.
europepmc   +1 more source

Thrombolytic agents, more options, more challenges. [PDF]

Stroke Vasc Neurol
Dong Y, Xu L, Hong L, Liu Y, Tu W, Zheng H, Leng X, Xiong Y, Cheng X, Wang DZ.   +9 more
europepmc   +1 more source

Real-world efficacy and safety of Tenecteplase versus Alteplase in acute ischemic stroke: a propensity score-matched analysis. [PDF]

Front Neurol
Zhang P, Sun L, Wang L.
europepmc   +1 more source

Adjuvant therapy with total salvianolic acid injection enhances the safety and efficacy of recombinant prourokinase in ischemic stroke by mitigating blood-brain barrier disruption. [PDF]

J Transl Med
Wang XY, Li Q, Yan L, Wang D, Pan CS, Fan JY, Ma ZZ, Han JY.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Streptokinase—a clinically useful thrombolytic agent

Biotechnology Advances, 2004
Yusuf Chisti, Uttam C Banerjee, Anirban Banerjee   +2 more
exaly   +2 more sources